sellWeak cluster of 710b5-1 plan
John R Prestridge III sold $19k of ZFOX
Chief Product Officer at ZeroFox Holdings, Inc.. 16,530 shares at an average of $1.12, traded Mar 18, 2024, filed Mar 19, 2024.
Warning score
10Value
$19k
16,530 shares
Holdings after
343,627
-5% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +15RoleOfficer
- 0Trade size$19k at market
- 0Share of holdings soldSold 4.6% of holdings
- +15Cluster7 insiders selling within 14 days
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0000950170-24-033116, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 18, 2024 | SOpen-market sale Common Stock10b5-1 | -16,530 | $1.12 | $19k | 343,627 | Mar 19, 2024 |
Related signals
Other insiders at ZeroFox Holdings, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 23Weak | ZeroFox Holdings, Inc. | Timothy S Bender CFO and Treasurer | $36k 31,736 shares | -4% | |
| 10Weak | ZeroFox Holdings, Inc. | Thomas P FitzGerald General Counsel & Secretary | $19k 17,085 shares | -3% | |
| 29Weak | ZeroFox Holdings, Inc. | James Christopher Foster CEO and Chairman | $90k 80,542 shares | -1% | |
| 15Weak | ZeroFox Holdings, Inc. | Scott O'Rourke Chief Revenue Officer | $32k 28,385 shares | -4% | |
| 15Weak | ZeroFox Holdings, Inc. | Michael Morgan Price Chief Technology Officer | $32k 29,014 shares | -4% | |
| 20Weak | ZeroFox Holdings, Inc. | Kevin T Reardon Chief Operating Officer | $32k 28,908 shares | -4% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.